Category Archives: ALS Treatment

Brain development that occurs after birth is also important. Rebecca Saxe at MIT is working to understand the brain structures and activities responsible for social cognition, which allows us to consider the mental states of other people. Continue reading →

Within our guts is a tiny ecosystem populated by trillions of microorganisms. These germs affect digestion, the immune system, and even brain functioning. Scientists have also started investigating the potential role of gut bacteria in psychiatric and neurological conditions, including neurodegenerative diseases like Alzheimers and Parkinsons Continue reading →

Researchers at the UCF College of Medicine have discovered a new technology to accelerate wound-healing. Continue reading →

Thousand Oaks-based startup Capsida Biotherapeutics launched in April with the goal of treating devastating diseases using gene therapy. The company just announced a big break that could accelerate its plans Continue reading →

NIH Senior Scientist Dr. Continue reading →

Joanne is a much more eloquent speaker, he starts, before Joanne interjects, Its because I talk all the time! Two & Out PETERS: Midway through the vaccine rollout, NACI's curveball was not helpful Sound Off SOUND OFF: As we move forward, we must not forget Sound Off SOUND OFF: Our work toward reconciliation Since Ross was diagnosed, Joanne says their friends and family have been there from Day One. Meals are regularly dropped off, the lawn gets mowed, and help is offered for any other tasks around the house. While some friends may not know how to handle the news or how to act as comfortably as before, Joanne says no one has shied away. Continue reading →

Six years ago, a teenager from Italy traveled to the U.S. in hopes of finding a diagnosis for her mysterious medical condition, which had caused her to lose the ability to walk and required her to have a breathing tube. Now, researchers have diagnosed the teenager, Claudia Digregorio, and 10 other children with a new form of amyotrophic lateral sclerosis (ALS) that strikes in childhood and progresses more slowly than what is typically seen with this condition. Continue reading →

NIH researchers discovered a new form of ALS that begins in childhood. The study linked the disease to a gene called SPLTC1. As part of the study, NIH senior scientist Carsten Bonnemann, M.D., (right) examined Claudia Digregorio (left), a patient from the Apulia region of Italy. Continue reading →

-Featuring Stanley H. Appel, M.D., internationally renowned researcher and neurologist--Webinar to be held Friday, June 11, 2021 at 11:30 a.m. ET- HOUSTON, June 02, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc., (Coya), a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous regulatory T cells (Tregs) and Treg-derived exosome therapeutics for neurodegenerative and autoimmune diseases, today announced that it will host a key opinion leader (KOL) webinar on ALS001, the Companys lead asset for the treatment of amyotrophic lateral sclerosis (ALS), on Friday, June 11, 2021 at 11:30 a.m. Continue reading →

By sequencing the genomes of 11 individuals with a severe form of childhood amyotrophic lateral sclerosis (ALS), a team led by National Institutes of Health researchers has identified a set of rare mutations that cause the disease. In these patients, they discovered variants in the gene SPTLC1, which is involved in lipid metabolism, and found that these mutations disrupt the production of an enzyme called serine palmitoyltransferase (SPT), leading to unrestrained sphingolipid production and accumulation in the motor neurons affected in ALS. Continue reading →